Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways
暂无分享,去创建一个
T. Roberts | A. D’Andrea | D. Barber | P. Rose | H. Luo | W. P. Hanratty | S. Lee | C. Dearolf | A D D'Andrea | T M Roberts | H Luo | P Rose | D Barber | W P Hanratty | S Lee | C R Dearolf | S. Lee | W. Hanratty | Alan D. D’Andrea | Hong Luo | Paul Rose | Dwayne Barber | Sue Lee | Thomas M. Roberts
[1] D. Lindsley,et al. The Genome of Drosophila Melanogaster , 1992 .
[2] H. Luo,et al. An amino acid substitution in the Drosophila hopTum‐l Jak kinase causes leukemia‐like hematopoietic defects. , 1995, The EMBO journal.
[3] L. Velazquez,et al. Distinct Domains of the Protein Tyrosine Kinase tyk2 Required for Binding of Interferon-/ and for Signal Transduction * , 1995, The Journal of Biological Chemistry.
[4] N. Perrimon,et al. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. , 1995, The EMBO journal.
[5] T. Hunter,et al. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.
[6] Ursula Klingmüller,et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.
[7] S. Akira,et al. Essential role of Stat6 in IL-4 signalling , 1996, Nature.
[8] W. Paul,et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.
[9] C. Dearolf,et al. Developmental consequences of awdb3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesis. , 1988, Developmental biology.
[10] D. Levy,et al. Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.
[11] N. Andrews,et al. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.
[12] J. Johnston,et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) , 1995, Nature.
[13] O. Silvennoinen,et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.
[14] Claude Desplan,et al. Identification of a Stat Gene That Functions in Drosophila Development , 1996, Cell.
[15] M. Kaplan,et al. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.
[16] J. Ryerse,et al. A genetic melanotic neoplasm of Drosophila melanogaster. , 1981, Developmental biology.
[17] Norbert Perrimon,et al. marelle Acts Downstream of the Drosophila HOP/JAK Kinase and Encodes a Protein Similar to the Mammalian STATs , 1996, Cell.
[18] D. Barber,et al. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation , 1994, Molecular and cellular biology.
[19] D. Zinyk,et al. Drosophila awdK–pn, a homologue of the metastasis suppressor gene nm23, suppresses the Tum–I haematopoietic oncogene , 1993, Nature Genetics.
[20] J. Ihle. STATs: Signal Transducers and Activators of Transcription , 1996, Cell.
[21] N. Aoki,et al. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. , 1994, The Journal of biological chemistry.
[22] P. Doherty,et al. Defective Lymphoid Development in Mice Lacking Jak3 , 1995, Science.
[23] M. Krasnow,et al. Transcriptional activation and repression by Ultrabithorax proteins in cultured Drosophila cells , 1989, Cell.
[24] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[25] A. Nappi,et al. Cell surface changes associated with cellular immune reactions in Drosophila. , 1984, Science.
[26] A. Levitzki,et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.
[27] A. Andres,et al. JAK2, a third member of the JAK family of protein tyrosine kinases. , 1992, Oncogene.
[28] B. Groner,et al. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. , 1994, The EMBO journal.
[29] W. Leonard,et al. Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.
[30] H. Erdjument-Bromage,et al. Interleukin‐3 signals through multiple isoforms of Stat5. , 1995, The EMBO journal.
[31] H. Sadowski,et al. Cell-free activation of a DNA-binding protein by epidermal growth factor , 1993, Nature.
[32] M. White,et al. Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1 (*) , 1995, The Journal of Biological Chemistry.
[33] R. Schreiber,et al. Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.
[34] T. Hunter,et al. JAK2, Ras, and Raf Are Required for Activation of Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase by Growth Hormone (*) , 1995, The Journal of Biological Chemistry.
[35] N. Perrimon,et al. Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. , 1994, Genes & development.
[36] J. Biggs,et al. Molecular consequences of awdb3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesis. , 1988, Developmental biology.
[37] Gretchen L. Humason,et al. Animal Tissue Techniques , 1974 .
[38] H. Luo,et al. A JAK-STAT pathway regulates wing vein formation in Drosophila. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Darnell,et al. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. , 1989, Genes & development.
[40] N. Perrimon,et al. l(1)hopscotch, A larval-pupal zygotic lethal with a specific maternal effect on segmentation in Drosophila. , 1986, Developmental biology.
[41] T. He,et al. Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. , 1994, Biochemical and Biophysical Research Communications - BBRC.
[42] A. Sharpe,et al. Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3 , 1995, Science.
[43] O. Silvennoinen,et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.
[44] M. Fellous,et al. A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.
[45] T. He,et al. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway , 1995, The Journal of Biological Chemistry.
[46] M. Summers,et al. A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. , 1987 .
[47] J. Darnell,et al. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.
[48] Michael Chinkers,et al. The protein kinase domain of the ANP receptor is required for signaling. , 1989, Science.